Skip to main content

Reimagining commercial in life sciences

Enhance the commercial pharma ecosystem with our solutions and perspectives

In the dynamic life sciences and pharma landscape, traditional commercial models often fall short. Seizing the opportunity to lead transformative change is critical. With innovative strategies in sales, marketing, and market access—powered by our deep data and tech capabilities—your business can develop a sustainable industry advantage. Our suite of services empowers organizations to excel through disruption and adapt swiftly to evolving customer and patient expectations. Discover how we can help you strengthen your commercial pharma capabilities and position your business at the forefront of the industry in this era of rapid change.

Commercial services grounded in data-rich capabilities

Life sciences innovators are tirelessly working to develop therapies, treatments, devices, and cures that address society’s most pressing health needs. At Deloitte, it’s our goal to help bridge the gap between scientific innovation and commercial pharma success. Through our IndustryAdvantage™ approach, we help organizations transform their core commercial functions, enhancing operational efficiencies and market responsiveness.

Our data-driven approach connects the right people, partners, and technologies to effectively orchestrate and elevate the business of science. By shaping robust commercial operations strategies, optimizing product portfolios, and integrating Generative AI into marketing workflows, we can help build essential capabilities that drive innovation and accelerate brand value realization. Leveraging life sciences commercial analytics, we help businesses hone their competitive edge to thrive in a rapidly shifting marketplace.

CognitiveSpark™ for Marketing

Life sciences companies rely on sustained marketing to drive reach, awareness, conversion, and loyalty. But are you delivering personalized interactions? And are you optimizing a return on your brand spend? Take a closer look at how ConvergeHEALTH CognitiveSpark™ for Marketing leverages AI to boost customer engagement and improve pharma ROI.

ConvergeHEALTH | Fierce webinar: Market access and pricing with Miner™ Access

Biopharmaceutical drug pricing and market access contracting has become more complicated and interrelated than ever. Learn about a more integrated and intuitive approach to linking pricing, contracting, and value-based decisions to create organizational agility and an ability to scale in this quickly changing complex landscape. Tune in to discover how this interconnected approach can have a radical impact on the profitability of life sciences organizations as well as align incentives across the health care ecosystems.

 

Join Deloitte at Asembia's AXS25 Summit

Attend our session to gain valuable insights into the Inflation Reduction Act and the women's health market:

Navigating the IRA: What have we learned? What is on the horizon?
Tuesday, April 29, 1:00 PM–1:40 PM PT (Margaux 2)

Join Principal Brian Corvino of Deloitte Consulting LLP and Blasine Penkowski, former Chief Strategic Customer Officer at Johnson & Johnson, for this discussion on the Inflation Reduction Act's effects on manufacturer assets and portfolios.

"Unlocking the potential of the ~$90 billion women's health market by 2030."
Wednesday, April 30, 12:00 PM–1:30 PM PT (Lafite 1-2)

Advisory Principal Jen Radin of Deloitte & Touche LLP will moderate a panel exploring how data, analytics, research, and investor markets can drive growth in this substantial market. The panel includes Michael Annichine, Chief Executive Officer of Magee-Womens Research Institute and Foundation, and Stephanie Sassman, Women's Health Portfolio Leader at Genentech.

Save the date and plan to join us at Asembia's AXS25 Summit!

Learn more

Are you looking to make a career move?

If you’re interested in joining our team, explore our job openings and sort by "life sciences."

Unlock value with our reimagined commercial services

If you’d like to talk about how to elevate your company’s commercial model strategies and strengthen its sales through data and analytics, let’s set up a conversation.

Commercial services grounded in data-rich capabilities

 

Life sciences innovators are tirelessly working to develop therapies, treatments, devices, and cures that address society’s most pressing health needs. At Deloitte, it’s our goal to help bridge the gap between scientific innovation and commercial pharma success. Through our IndustryAdvantage™ approach, we help organizations transform their core commercial functions, enhancing operational efficiencies and market responsiveness.

Our data-driven approach connects the right people, partners, and technologies to effectively orchestrate and elevate the business of science. By shaping robust commercial operations strategies, optimizing product portfolios, and integrating Generative AI into marketing workflows, we can help build essential capabilities that drive innovation and accelerate brand value realization. Leveraging life sciences commercial analytics, we help businesses hone their competitive edge to thrive in a rapidly shifting marketplace.

Life sciences innovators are tirelessly working to develop therapies, treatments, devices, and cures that address society’s most pressing health needs. At Deloitte, it’s our goal to help bridge the gap between scientific innovation and commercial pharma success. Through our IndustryAdvantage™ approach, we help organizations transform their core commercial functions, enhancing operational efficiencies and market responsiveness.

Our data-driven approach connects the right people, partners, and technologies to effectively orchestrate and elevate the business of science. By shaping robust commercial operations strategies, optimizing product portfolios, and integrating Generative AI into marketing workflows, we can help build essential capabilities that drive innovation and accelerate brand value realization. Leveraging life sciences commercial analytics, we help businesses hone their competitive edge to thrive in a rapidly shifting marketplace.